Literature DB >> 17457104

Steady-state lopinavir levels in third trimester of pregnancy.

Fiona Lyons1, Martin Lechelt, Annemiek De Ruiter.   

Abstract

Stek and colleagues reported low lopinavir levels in the third trimester of pregnancy at standard dosing. Since their initial report in 2003, we have taken steady-state trough lopinavir levels in all pregnant women in the third trimester; the results of 26 women on a lopinavir/ritonavir regimen are reported. The median trough level was 3.66 microg/ml, range 0.25-9.97; the median HIV viral load was 49 copies/ml at delivery. All infants were HIV polymerase chain reaction negative at 3 months.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17457104     DOI: 10.1097/QAD.0b013e3281053a1e

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

1.  Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy.

Authors:  Tim R Cressey; Saik Urien; Edmund V Capparelli; Brookie M Best; Sudanee Buranabanjasatean; Aram Limtrakul; Boonsong Rawangban; Prapan Sabsanong; Jean-Marc Treluyer; Gonzague Jourdain; Alice Stek; Marc Lallemant; Mark Mirochnick
Journal:  J Antimicrob Chemother       Date:  2014-09-25       Impact factor: 5.790

2.  Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy.

Authors:  Tim R Cressey; Gonzague Jourdain; Boonsong Rawangban; Supang Varadisai; Rucha Kongpanichkul; Prapan Sabsanong; Prapap Yuthavisuthi; Somnuk Chirayus; Nicole Ngo-Giang-Huong; Nipunporn Voramongkol; Somsak Pattarakulwanich; Marc Lallemant
Journal:  AIDS       Date:  2010-09-10       Impact factor: 4.177

3.  PHARMACOKINETIC EXPOSURE AND VIROLOGIC RESPONSE IN HIV-1 INFECTED PREGNANT WOMEN TREATED WITH LOPINAVIR/RITONAVIR: AIDS CLINICAL TRIALS GROUP PROTOCOL A5153S: A SUBSTUDY TO A5150.

Authors:  Beverly E Sha; Camlin Tierney; Xin Sun; Alice Stek; Susan E Cohn; Robert W Coombs; Barbara Bastow; Francesca T Aweeka
Journal:  Jacobs J AIDS HIV       Date:  2015-05-16

4.  Antiretroviral regimens in pregnancy and breast-feeding in Botswana.

Authors:  R L Shapiro; M D Hughes; A Ogwu; D Kitch; S Lockman; C Moffat; J Makhema; S Moyo; I Thior; K McIntosh; E van Widenfelt; J Leidner; K Powis; A Asmelash; E Tumbare; S Zwerski; U Sharma; E Handelsman; K Mburu; O Jayeoba; E Moko; S Souda; E Lubega; M Akhtar; C Wester; R Tuomola; W Snowden; M Martinez-Tristani; L Mazhani; M Essex
Journal:  N Engl J Med       Date:  2010-06-17       Impact factor: 91.245

5.  Lopinavir tablet pharmacokinetics with an increased dose during pregnancy.

Authors:  Brookie M Best; Alice M Stek; Mark Mirochnick; Chengcheng Hu; Hong Li; Sandra K Burchett; Steven S Rossi; Elizabeth Smith; Jennifer S Read; Edmund V Capparelli
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

6.  Protein binding of lopinavir and ritonavir during 4 phases of pregnancy: implications for treatment guidelines.

Authors:  Kristine B Patterson; Julie B Dumond; Heather A Prince; Amanda J Jenkins; Kimberly K Scarsi; Ruili Wang; Stephanie Malone; Michael G Hudgens; Angela D M Kashuba
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

7.  Lopinavir exposure with an increased dose during pregnancy.

Authors:  Mark Mirochnick; Brookie M Best; Alice M Stek; Edmund Capparelli; Chengcheng Hu; Sandra K Burchett; Diane T Holland; Elizabeth Smith; Sreedhar Gaddipati; Jennifer S Read
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-15       Impact factor: 3.731

Review 8.  Antiretroviral medications during pregnancy for therapy or prophylaxis.

Authors:  Alice Marie Stek
Journal:  Curr HIV/AIDS Rep       Date:  2009-05       Impact factor: 5.071

Review 9.  Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

Authors:  Matthieu Roustit; Malik Jlaiel; Pascale Leclercq; Françoise Stanke-Labesque
Journal:  Br J Clin Pharmacol       Date:  2008-05-15       Impact factor: 4.335

10.  Therapeutic levels of lopinavir in late pregnancy and abacavir passage into breast milk in the Mma Bana Study, Botswana.

Authors:  Roger L Shapiro; Steven Rossi; Anthony Ogwu; Mary Moss; Jean Leidner; Claire Moffat; Shahin Lockman; Sikhulile Moyo; Joseph Makhema; Max Essex; Edmund Capparelli
Journal:  Antivir Ther       Date:  2012-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.